June 30, 2021
June 17, 2021
May 10, 2021
April 22, 2021
In the News
June 21, 2021
On May 7th, the European Commission published draft rules on how corporates and financial institutions should report on their alignment with the EU Taxonomy. The draft rules are laid out in a very technical document and not an easy read. This might explain why certain changes with significant impact on timelines and scope of the EU Taxonomy Regulation have flown under the radar of media and investors. Some of the impacts even escaped the attention of financial market participants responding to the consultation on the rules.
June 18, 2021
Foxberry today announced it is collaborating with Sustainalytics, a Morningstar company and a leading global provider of ESG research, ratings and data, to offer institutional investors access to a wide range of ESG information through the foxf9® platform. Leveraging Sustainalytics’ rich set of ESG ratings and data, investors can create unique indexes and assess their performance. Foxberry’s foxf9 platform enables clients to seamlessly assess multiple data sources in one place and the foxf9 calculation and back testing engine can provide a deeper level of understanding ESG data.
May 13, 2021
Sustainalytics' CEO Michael Jantzi Appointed to the Independent Review Committee on Standard Setting in Canada
The Independent Review Committee on Standard Setting in Canada (the Committee) will make recommendations to ensure Canadian standard setting will continue to be independent and internationally recognized. Playing a vital role in the financial and performance reporting supply chain, accounting, auditing, and assurance standards provide a common and essential measurement for Canadians to assess organizations and their financial results.
June 7, 2020
Sustainalytics has been awarded the Best Responsible Investment Integration Leadership Award by RIA Canada. The firm took the top spot for its ESG Risk Ratings †roll-out and its contribution to making responsible investment a more dominant trend in the Canadian investment industry.
Jul 12, 2021 | Biopharma ESG Risks from U.S. Pricing doesn't sway our valuation
Join Morningstar, Sustainalytics and the Institute for Clinical and Economic Review (ICER) to discuss the methodology in application to a core risk facing the biopharma group: new U.S. government policies aimed at reducing drug pricing to increase access for patients.
Asia Pacific: Navigating the EU SFDR Regulations
The EU Action Plan raises the bar for transparency and accountability on sustainable finance and the investment management industry. Hear from Sustainalytics' Anne Schoemaker, Associate Director, Product Strategy and Development and William Ridout, Senior Product Manager, for an insightful event for Asia Pacific investors focusing on EU Taxonomy and Sustainable Finance Disclosure Regulation (SFDR).
Is there a price to be paid for ESG Investing?
With a growing awareness around sustainability issues and accelerating regulatory developments in Europe, sustainable finance is one of the most significant talking points of our time. But what does sustainability investing mean for stakeholders and what are the resulting challenges? What’s more, what kind of impact does this have on a company’s mid to long-term strategy as well as its short-term profitability? By bringing together representatives from the regulatory side, the financial industry, the non-financial industry and an independent advisory firm, we aim to take a closer look at the consequences for the corporate world and answer a key question - is there a price to be paid for investing in ESG companies?